- Volume is elevated versus the 13-week average, confirming attention.
- Latest weekly return ranks in the strongest part of its sector group.
SYNT
LSE
Week ended 07 Aug 2026
Weekly Investor Report
Synthomer plc · Basic Materials · Specialty Chemicals
Latest close
1.22 GBP
38.6%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -96.8% below the Trend Line and sits at 0.4% of its 52-week range. The latest completed week returned 38.6%, after a 45.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 55/100.
Setup score
35
out of 100
Latest Close
1.22 GBP
7 Aug 2026
1W Return
38.6%
latest completed week
4W Return
45.8%
short-term follow-through
12W Return
-98.8%
quarterly tape
Trend Breadth
7.7%
4 of 52 weeks active
Volume Ratio
3.2x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
38.6%
Latest completed week; four-week move 45.8%.
Indicator stack
4/38
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.61%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
55/100
20 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -96.8% below the Trend Line and sits at 0.4% of its 52-week range. The latest completed week returned 38.6%, after a 45.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 3.2x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2612-week average 0.42
12-week confirmation
Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.26Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 45.8% over four weeks, -98.8% over 12 weeks, and -98.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year4
Trend breadth7.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.72Latest activity-pressure read.
Pressure change15.2%Four-week change in activity pressure.
Leadership-97.69Latest relative-leadership reading.
RS change0.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Dec 2025
Field coverage 79%
Model confidence 63%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength19/100Blend of value, momentum, and quality. Underlying universe rank 82; rank 1 is best.
Value29/100Relative valuation strength. Underlying universe rank 72; rank 1 is best.
Quality30/100Profitability and accounting quality. Underlying universe rank 71; rank 1 is best.
Momentum30/100Medium-term price momentum. Underlying universe rank 71; rank 1 is best.
Growth30/100Revenue and earnings growth. Underlying universe rank 71; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- - Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- - Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- - Gross profit retained from each unit of revenue.
- Operating margin
- 97.4% Operating profit retained from revenue.
- Free-cash-flow margin
- 2.1% Free cash flow generated from revenue.
- Return on invested capital
- 83.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -10.0% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- - Net share repurchases relative to market value.
- Shareholder yield
- - Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 11.7x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment55/100
Weighted news tone is neutral across 20 relevant articles.
4 positive · 16 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-99.0%Distance below the 52-week high.
13-week volatility30.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher17 of 269 weeks finished lower.
Best week+114.6%Week of 1 May.
Worst week-99.1%Week of 5 Jun.
Latest week+38.6%Week of 7 Aug.
Shape of recent returns
Strong gains12
Modest gains5
Flat weeks0
Modest losses3
Sharp losses6
Recent vol30.7%13-week weekly-return volatility.
Base vol26.9%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew15.1% / -14.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Basic Materials
4-week rank1 / 100
Group average5.9%
Trend breadth26.0%
Trend26.0%active weekly trend signals
MD33.0%positive activity pressure
RS43.0%positive relative leadership
Four-week leaders
IndustryGB Specialty Chemicals
4-week rank2 / 12
Group average19.9%
Trend breadth41.7%
Trend41.7%active weekly trend signals
MD58.3%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape28/100
Trend, activity pressure, participation, and risk combine to a 28/100 tape read.
Indicator analysis30/100Latest 12-week confirmation: trend 3/12, activity pressure 4/12, relative leadership 2/12.
Activity pressure 0.26; No reversal markers Next-Week ExpectancyNegative 41.61%Next-week expectancy is negative with a 41.61% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors26/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 50 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment55/100Weighted news tone is neutral across 20 relevant articles.
Synthomer plc Revenue Breakdown – LSE:SYNT Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1.22 GBP | 38.6% | 38.25 GBP | 147.6 GBP | -0.72 | -97.69 | 10.2M | Off |
| 31 Jul 2026 | 0.88 GBP | 4.0% | 40.32 GBP | 151.6 GBP | -0.82 | -98.38 | 3.1M | Off |
| 24 Jul 2026 | 0.85 GBP | 2.3% | 42.36 GBP | 155.4 GBP | -0.89 | -98.49 | 1.7M | Off |
| 17 Jul 2026 | 0.83 GBP | -1.2% | 44.35 GBP | 159.2 GBP | -0.88 | -98.56 | 2.0M | Off |
| 10 Jul 2026 | 0.84 GBP | -4.9% | 46.39 GBP | 163.0 GBP | -0.84 | -98.58 | 2.7M | Off |
| 3 Jul 2026 | 0.88 GBP | 10.3% | 48.32 GBP | 166.7 GBP | -0.77 | -98.59 | 576.4K | Off |
| 26 Jun 2026 | 0.80 GBP | -30.4% | 50.39 GBP | 170.1 GBP | -0.63 | -98.75 | 1.8M | Off |
| 19 Jun 2026 | 1.15 GBP | -1.2% | 52.01 GBP | 173.5 GBP | -0.13 | -98.25 | 1.4M | Off |
| 12 Jun 2026 | 1.16 GBP | 12.4% | 53.75 GBP | 177.4 GBP | 0.36 | -98.31 | 701.2K | Off |
| 5 Jun 2026 | 1.03 GBP | -99.1% | 55.24 GBP | 181.6 GBP | 0.81 | -98.54 | 1.0M | On |
| 29 May 2026 | 108.8 GBP | 1.9% | 57.00 GBP | 185.9 GBP | 1.27 | 48.79 | 3.4M | On |
| 22 May 2026 | 106.8 GBP | 3.5% | 55.31 GBP | 189.9 GBP | 1.38 | 44.88 | 8.4M | On |
| 15 May 2026 | 103.2 GBP | 2.6% | 53.66 GBP | 194.3 GBP | 1.12 | 43.11 | 4.9M | On |
| 8 May 2026 | 100.6 GBP | 3.7% | 52.27 GBP | 198.9 GBP | 0.90 | 38.41 | 10.7M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.